Wade D Miquelon sold $188k of ACHC
director at Acadia Healthcare Company, Inc.. 2,203 shares at an average of $85.39, traded Mar 5, 2024, filed Mar 6, 2024.
Score components
- +15RoleDirector
- +12Trade size$188k at market
- 0Share of holdings soldSold 4.6% of holdings
- +8Cluster2 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -10.3%, 3m -15.9%, 6m -6.6%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-24-027357, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 5, 2024 | SOpen-market sale Common Stock | -2,203 | $85.39 | $188k | 46,074 | Mar 6, 2024 |
Related signals
Other insiders at Acadia Healthcare Company, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 35Weak | Acadia Healthcare Company, Inc. | Vicky B Gregg director | $214k 2,500 shares | -9% | |
| 40Moderate | ACHCsell Acadia Healthcare Company, Inc. | Debra K Osteen Chief Executive Officer | $3.3M 43,000 shares | -6% | |
| 68Notable | Acadia Healthcare Company, Inc. | John S. Hollinsworth EVP of Operations | $6.8M 92,500 shares | -52% | |
| 48Moderate | Acadia Healthcare Company, Inc. | Debra K Osteen Chief Executive Officer | $1.1M 15,000 shares | -2% | |
| 53Moderate | Acadia Healthcare Company, Inc. | John S. Hollinsworth EVP of Operations | $2.4M 32,500 shares | -16% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.